| Identification | Back Directory | [Name]
AZD-1208 | [CAS]
1204144-28-4 | [Synonyms]
CS-794
AZD1208
AZD-1208
AZD 1208
AZD1208 >=95%
AZD 1208;AZD-1208
AZD-1208 USP/EP/BP
AZD1208;AZD 1208;AZD-1208
(R,Z)-5-((2-(3-aminopiperidin-1-yl)biphenyl-3-yl)methylene)thiazolidine-2,4-dione
(R,Z)-5-((2-(3-aMinopiperidin-1-yl)-[1,1'-biphenyl]-3-yl)Methylene)thiazolidine-2,4-dione
(5Z)-5-[[2-[(3R)-3-aMino-1-piperidinyl][1,1'-biphenyl]-3-yl]Methylene]-2,4-thiazolidinedione
(5Z)-5-[[2-[(3R)-3-aminopiperidin-1-yl]-3-phenylphenyl]methylidene]-1,3-thiazolidine-2,4-dione
2,4-Thiazolidinedione, 5-[[2-[(3R)-3-amino-1-piperidinyl][1,1'-biphenyl]-3-yl]methylene]-, (5Z)-
(5Z)-5-[[2-[(3R)-3-Amino-1-piperidinyl][1,1'-biphenyl]-3-yl]methylene]-2,4-thiazolidinedione AZD1208 | [Molecular Formula]
C21H21N3O2S | [MDL Number]
MFCD25976757 | [MOL File]
1204144-28-4.mol | [Molecular Weight]
379.475 |
| Chemical Properties | Back Directory | [Melting point ]
>220°C (dec.) | [density ]
1.307±0.06 g/cm3(Predicted) | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
DMSO (Slightly) | [form ]
Solid | [pka]
7.39±0.20(Predicted) | [color ]
Off-White to Pale Yellow |
| Hazard Information | Back Directory | [Uses]
AZD1208 is a potent, and orally available Pim kinase inhibitor. | [Biological Activity]
upregulation of pim kinases has been observed in several types of leukemias and lymphomas. pim-1, -2, and -3 promote cell proliferation and survival downstream of cytokine and growth factor signaling pathways. azd1208 is a potent, highly selective, and orally available pim kinase inhibitor. | [in vitro]
azd1208 inhibited the growth of 5 of 14 acute myeloid leukemia (aml) cell lines tested. in molm-16 cells, azd1208 also causes cell cycle arrest and apoptosis, accompanied by a dose-dependent reduction in phosphorylation of bcl-2 antagonist of cell death [1]. | [Enzyme inhibitor]
This orally available protein kinase inhibitor (FW = 379.48 g/mol; CAS
1204144-28-4; Soluble in DMSO, Insoluble in H2O), also named 5-[[2-
[ (3R) -3-aminopiperidin-1-yl]biphenyl-3-yl]methylidene]-1,3-thiazolidine-
2,4-dione, targets the proto-oncogene serine/threonine-protein kinases
PIM-1, PIM-2 and PIM-3, often interrupting the G1/S cell cycle transition
and inducing apoptosis in PIM-overexpressing cells. Pim kinases are
downstream effectors of ABL, JAK2, and Flt-3 oncogenes that are critical
for driving tumorigenesis. PIM1, PIM2 and PIM3 were first recognized
as pro-viral integration sites for the Moloney Murine Leukemia virus.
Unlike other kinases, they possess a hinge region which creates a unique
binding pocket for ATP. Absence of a regulatory domain makes these
proteins are constitutively active once transcribed. Upregulation of Pim
kinases is observed in several types of leukemias (especially Acute
Myelogenous Leukemia (AML) ) and lymphomas, with PIM-1, PIM-2 and
PIM-3 promoting cancer cell proliferation and survival. AZD1208,
demonstrates efficacy in preclinical models of acute myeloid leukemia.
| [in vivo]
azd1208 inhibits the growth of kg-1a and molm-16 xenograft tumors in vivo with a clear pk/pd relationship. treatment with 10 mg/kg or 30 mg/kg of azd1208 led to an 89% tumor growth inhibition or slight regression, respectively [1]. | [target]
Pim1 | [IC 50]
0.4 nm for pim-1, 5.0 nm for pim-2, and 1.9 nm for pim-3 | [storage]
Store at -20°C | [References]
[1] keeton ek, mceachern k, dillman ks, palakurthi s, cao y, grondine mr, kaur s, wang s, chen y, wu a, shen m, gibbons fd, lamb ml, zheng x, stone rm, deangelo dj, platanias lc, dakin la, chen h, lyne pd, huszar d. azd1208, a potent and selective pan-pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia. blood. 2014;123(6):905-13. |
|
|